Biocon Ltd

NSE :BIOCON   BSE :532523  Sector : Pharmaceuticals
Buy, Sell or Hold BIOCON? Ask The Analyst

BSE


prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE


prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

27 Mar
256.60
(-0.43%)
26 Mar
257.70
(2.18%)
22 Mar
252.20
(1.41%)
21 Mar
248.70
(0.75%)
20 Mar
246.85
(0.45%)
19 Mar
245.75
(-1.95%)
18 Mar
250.65
(-0.40%)
15 Mar
251.65
(-5.89%)
14 Mar
267.40
(5.75%)
13 Mar
252.85
(-6.47%)
12 Mar
270.35
(-3.17%)
11 Mar
279.20
(-0.96%)
07 Mar
281.90
(2.70%)
06 Mar
274.50
(-1.95%)
05 Mar
279.95
(0.38%)
04 Mar
278.90
(0.70%)
02 Mar
276.95
(1.11%)
01 Mar
273.90
(-0.94%)
29 Feb
276.50
(2.01%)
28 Feb
271.05
(-1.69%)
27 Feb
275.70
(1.01%)


Technical Analysis

Short Term Investors

Bearish

Medium Term Investors

Very Bearish

Long Term Investors

Neutral

Moving Averages

5 DMA
Bullish

252.49


10 DMA
Bullish

253.02


20 DMA
Bearish

264.66


50 DMA
Bearish

270.96


100 DMA
Bearish

259.17


200 DMA
Bearish

257.02



Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Mar 27, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 268.69 265.97 258.64 - -
R2 265.97 263.14 257.96 265.48 -
R1 261.29 261.4 257.28 260.31 263.63
P 258.57 258.57 258.57 258.08 259.74
S1 253.89 255.74 255.92 252.91 256.23
S2 251.17 254 255.24 250.68 -
S3 246.49 251.17 254.57 - -

Key Metrics

EPS

0.4

P/E

0

P/B

2.84

Dividend Yield

0.58%

Market Cap

30,807 Cr.

Face Value

5

Book Value

90.38

ROE

6.64%

EBITDA Growth

1,488.4 Cr.

Debt/Equity

0.88

Shareholding Pattern

  60.64% Total Promoter Holding
9.31% Mutual Fund Holdings
6.55% FIIs
17.96% Non Institution
5.12% Insurance Companies
0.33% Custodians
0.09% Other Parties

Shareholding History


Quarterly Result (Figures in Rs. Crores)


Biocon Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 3019.7 3928.8 3516.1 3620.2 4540.4
PROFIT 170.6 315.7 101.4 143.74 640.97
EPS -0.35 2.62 0.85 1.05 5.52

Biocon Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 614.9 2424.3 568.9 588.3 611.3
PROFIT 35.2 -42.8 28.45 38.62 24
EPS 0.29 15.17 0.39 0.29 0.2

Profit & Loss (Figures in Rs. Crores)


Biocon Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 2932.7 3329.6 3757.2 4133.5 4392.6 6064 6730.2 7700.3 8653.3 11704.2
PROFIT 412.32 410.01 345.56 609.16 328.65 725.03 690.28 729.97 747.32 692.56
EPS 3.45 4.23 5.08 5.73 3.78 8.36 7.26 7.05 6.43 5.36

Biocon Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 2261.8 2429.9 2617.4 2733.2 2545.7 2276.8 2385.8 2141.9 2031.2 5123.9
PROFIT 322.9 378.19 302.77 516.38 213.46 326.06 304.63 277.5 83.18 -13.33
EPS 2.56 2.99 3.07 4.33 1.99 4.11 3.67 2.34 0.72 23.72

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 600.3600.3600600300300100100100100
Reserves Total 17,266.67,832.27,026.96,105.85,7984,880.84,737.73,933.83,170.62,926.7
Total Shareholders Funds17,866.98,432.57,626.96,705.86,0985,180.84,837.74,033.83,270.63,026.7
Minority Interest4,621.91,037.5880.7677.3608.9467.7376.1265.8172.282.3
Secured Loans 13,7952,621.72,295.22,041.82,214.22,166.42,233.82,237.4830.8756.8
Unsecured Loans 4,223.82,524.92,185.9673.5207.997.668.7240.3286.4106.9
Total Debt18,018.85,146.64,481.12,715.32,422.12,2642,302.52,477.71,117.2863.7
Other Liabilities5,161.92,823.72,696.61,717.6906.3410.1393.9420.4566.6610.8
Total Liabilities45,669.517,440.315,685.311,81610,035.38,322.67,910.27,197.75,126.64,583.5
APPLICATION OF FUNDS :
Gross Block 35,321.411,23310,220.99,147.47,0955,873.85,431.43,403.63,042.32,709.8
Less: Accumulated Depreciation5,853.74,6643,8573,176.32,6242,174.31,805.51,655.31,412.41,184.6
Net Block29,467.76,5696,363.95,971.14,4713,699.53,625.91,748.31,629.91,525.2
Capital Work in Progress7,3174,110.42,800.22,1961,898.91,302.8839.22,239.51,676.61,205.6
Investments 2,068.81,587.91,951.9966.11,011.8675.21,253901.5230.3764.9
Inventories 4,243.72,298.21,866.61,435.91,031.6722.5635.3542.4452.7376.6
Sundry Debtors 3,573.22,058.21,503.31,223.71,291.81,063.9883.2714.5770.5599.8
Cash and Bank Balance2,400.11,747.52,015.4998.61,057.21,322.81,044.31,538.6937.5804.4
Loans and Advances 790.51,060.71,006.4809.2678.6428419.9300.7171.6157.6
Total Current Assets11,007.57,164.66,391.74,467.44,059.23,537.22,982.73,096.22,332.31,938.4
Current Liabilities 5,617.92,609.12,542.92,367.11,952.81,531.51,340.81,126.51,048.9945.5
Provisions 373.6292.3261.8230.9204.3135.6143.2133.9158.2176.6
Total Current Liabilities & Provisions5,991.52,901.42,804.72,5982,157.11,667.11,4841,260.41,207.11,122.1
Net Current Assets5,0164,263.23,5871,869.41,902.11,870.11,498.71,835.81,125.2816.3
Deferred Tax Assets1,802.81,150.1307.7368558.1295.9289.1140.112.39
Deferred Tax Liability1,883.6909.132.329.8233.4102.591.668.65454
Net Deferred Tax-80.8241275.4338.2324.7193.4197.571.5-41.7-45
Other Assets1,880.8668.8706.9475.2426.8581.6495.9401.1506.3316.5
Total Assets45,669.517,440.315,685.311,81610,035.38,322.67,910.27,197.75,126.64,583.5
Contingent Liabilities947.8844.47001,4191,601.1588.9594590.5364.7314.7
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 600.3600.3600600300300100100100100
Reserves Total 10,315.77,492.67,307.16,937.36,815.46,438.66,441.15,896.62,484.42,317.7
Total Shareholders Funds10,9168,092.97,907.17,537.37,115.46,738.66,541.15,996.62,584.42,417.7
Secured Loans 1,297.775.90069.3130.2129.6132.8081.5
Unsecured Loans 3.513.142.12.83.9236.781.539.9
Total Debt1,301.276.93.1471.4133133.5369.581.5121.4
Other Liabilities116109.2115.242.2130.389.590.2101.5136.4131.1
Total Liabilities12,333.28,2798,025.47,583.57,317.16,961.16,764.86,467.62,802.32,670.2
APPLICATION OF FUNDS :
Gross Block 2,4722,269.72,098.11,993.32,581.32,236.72,128.91,934.41,832.11,730
Less : Accumulated Depreciation 1,510.61,399.51,3001,200.11,480.21,334.11,190.91,040.6917.8780.7
Net Block 961.4870.2798.1793.21,101.1902.6938893.8914.3949.3
Capital Work in Progress343.5284.9179.2151.9254.5318.5240.8172.357.6101.8
Investments 9,270.75,2805,412.74,952.84,093.14,1993,888.23,852.8164.7493.2
Inventories 560.1541.5430.9534.7801.9561.7539.6504.6406.3357.6
Sundry Debtors 658700.6605.4573.2901.8739.9798.2503.8555.1494.6
Cash and Bank Balance720.3689.3601.2375.3356196.9382.9643621.2204.2
Loans and Advances 306.7208.6192.5461.7338.3105.4133.1121.46962.6
Total Current Assets2,245.12,1401,8301,944.92,3981,603.91,853.81,772.81,651.61,119
Current Liabilities 571.3474.3435.6618.1788.2660.2594.4528.2347.1344.4
Provisions 125.4115.7112.7109.2135.1105.6109.7101.4146.8163.9
Total Current Liabilities & Provisions696.7590548.3727.3923.3765.8704.1629.6493.9508.3
Net Current Assets1,548.41,5501,281.71,217.61,474.7838.11,149.71,143.21,157.7610.7
Deferred Tax Assets44.9159.6195.4226.3258158.8162.307.25.2
Deferred Tax Liability22.139.64946.856.156.656.90.94445.2
Net Deferred Tax22.8120146.4179.5201.9102.2105.4-0.9-36.8-40
Other Assets186.4173.9207.3288.5191.8600.7442.7406.4544.8555.2
Total Assets12,333.28,2798,025.47,583.57,317.16,961.16,764.86,467.62,802.32,670.2
Contingent Liabilities681.7525.71,574.92,225.82,160.61,677.71,668.51,532.91,082.7751.7

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...643
Depreciation1,113.1
Interest (Net)306.6
P/L on Sales of Assets5.2
P/L on Sales of Invest-258.6
Prov. and W/O (Net)6.4
P/L in Forex97.1
Others1,172.1
Total Adjustments (PBT and Ext...1,939.1
Operating Profit before Workin...2,582.1
Trade and 0ther Receivables1,590.5
Inventories886.2
Trade Payables-3,735.9
Total Adjustments (OP before W...-501
Cash Generated from/(used in) ...2,081.1
Direct Taxes Paid-228.6
Total Adjustments(Cash Generat...-228.6
Cash Flow before Extraordinary...1,852.5
Net Cash from Operating Activi...1,852.5
Purchased of Fixed Assets-1,726.3
Sale of Fixed Assets3.1
Purchase of Investments-16,311.2
Sale of Investments16,151.5
Interest Received123.3
Cancellation of Investment in ...3,447.4
Net Cash used in Investing Act...-14,260.1
Proceeds from Issue of shares ...29.5
Proceed from 0ther Long Term B...10,939.9
Proceed from Short Tem Borrowi...1,504.1
Of the Long Tem Borrowings-28.1
Of Financial Liabilities-11.4
Dividend Paid-71.8
Interest Paid-485.6
Net Cash used in Financing Act...13,048.7
Net Profit before Tax and Extr...2,848.4
Depreciation116.9
Interest (Net)34.2
Dividend Received49.5
P/L on Sales of Assets0.1
P/L on Sales of Invest-2,886.7
Prov. and W/O (Net)20.1
P/L in Forex-4.5
Others-64.7
Total Adjustments (PBT and Ext...-2,604.1
Operating Profit before Workin...244.3
Trade and 0ther Receivables22.9
Inventories-18.6
Trade Payables118.4
Total Adjustments (OP before W...16.1
Cash Generated from/(used in) ...260.4
Direct Taxes Paid-41.1
Total Adjustments(Cash Generat...-41.1
Cash Flow before Extraordinary...219.3
Net Cash from Operating Activi...219.3
Purchased of Fixed Assets-266.8
Sale of Fixed Assets2.6
Purchase of Investments-7,371.1
Sale of Investments7,251.9
Interest Received46.5
Invest.In Subsidiaires-4,071
Loans to Subsidiaires-32.5
Cancellation of Investment in ...3,447.4
Net Cash used in Investing Act...-1,173.1
Proceeds from Issue of shares ...29.5
Proceed from 0ther Long Term B...1,187.1
Proceed from Short Tem Borrowi...2,515.3
Of the Short Term Borrowings-2,515.3
Of Financial Liabilities-1.4
Dividend Paid-60
Interest Paid-51.1
Net Cash used in Financing Act...1,039.4

Company Details

Registered Office
Address20th KM Hosur Road Hebbagodi,
Electronic City P O
CityBangalore
StateKarnataka
Pin Code560100
Tel. No.91-80-28082808
Fax. No.91-80-28523423
Emailco.secretary@biocon.com
Internethttp://www.biocon.com
Registrars
Address20th KM Hosur Road Hebbagodi
CityBangalore
StateKarnataka
Pin Code560100
Tel. No.91-80-28082808
Fax. No.91-80-28523423
Emailco.secretary@biocon.com
Internethttp://www.biocon.com
Management
Name Designation
Kiran Mazumdar ShawChairperson
Ravi MazumdarDirector
Vijay Kumar KuchrooIndependent Director
M DamodaranIndependent Director
Bobby ParikhIndependent Director
Mayank VermaCompany Sec. & Compli. Officer
SIDDHARTH MITTALManaging Director & CEO
Eric Vivek MazumdarDirector
Naina Lal KidwaiIndependent Director
Peter John BainsIndependent Director